Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment
暂无分享,去创建一个
Alain Giron | Michel Zanca | Marie-Odile Habert | Bruno Dubois | Jean-François Horn | Marie Sarazin | Marc Verny | B. Dubois | M. Zanca | J. Touchon | M. Sarazin | B. Fertil | M. Habert | F. Portet | J. Lotterie | M. Puel | M. Verny | A. Giron | F. Onen | Jean-François Horn | Jacques Touchon | Bernard Fertil | Jean-Albert Lotterie | Fannie Onen | F. Mahieux | Michèle Puel | Florence Portet | Florence Mahieux | Alain Giron
[1] W. Jagust,et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers , 1992, Neurology.
[2] P. Scheltens,et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria , 2007, The Lancet Neurology.
[3] A. Barabash,et al. Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[4] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[5] Takashi Asada,et al. Brain SPET abnormalities in Alzheimer's disease before and after atrophy correction , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[6] Robin B. Holmes,et al. The contribution of statistical parametric mapping in the assessment of precuneal and medial temporal lobe perfusion by 99mTc-HMPAO SPECT in mild Alzheimer's and Lewy body dementia , 2005, Nuclear medicine communications.
[7] G K Wilcock,et al. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[8] Hiroshi Matsuda,et al. Role of Neuroimaging in Alzheimer's Disease, with Emphasis on Brain Perfusion SPECT* , 2007, Journal of Nuclear Medicine.
[9] D. Perani,et al. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. , 2005, Archives of neurology.
[10] J. Baron,et al. Mild cognitive impairment , 2003, Neurology.
[11] M. Freedman,et al. Frontotemporal lobar degeneration , 1998, Neurology.
[12] S. DeKosky,et al. Mild cognitive impairment, amnestic type , 2004, Neurology.
[13] Ingeborg Goethals,et al. Analysis of clinical brain SPECT data based on anatomic standardization and reference to normal data: an ROC-based comparison of visual, semiquantitative, and voxel-based methods. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] H. Matsuda,et al. Partial volume effect-corrected FDG PET and grey matter volume loss in patients with mild Alzheimer’s disease , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[15] J Bohl,et al. Staging of Alzheimer-Related Cortical Destruction , 1997, International Psychogeriatrics.
[16] G. Goldstein,et al. Does the right hemisphere age more rapidly than the left? , 1981, Journal of clinical neuropsychology.
[17] Brian D. Ripley,et al. Pattern Recognition and Neural Networks , 1996 .
[18] O Almkvist,et al. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment , 2001, Neuroreport.
[19] N. Tzourio-Mazoyer,et al. Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.
[20] Hiroshi Matsuda,et al. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT , 2005, NeuroImage.
[21] Roberto Cabeza,et al. Role of parietal regions in episodic memory retrieval: The dual attentional processes hypothesis , 2008, Neuropsychologia.
[22] K. Kosaka,et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.
[23] B. Dubois,et al. Early detection of patients in the pre demented stage of Alzheimer’s disease: The Pre-Al study , 2009, The journal of nutrition, health & aging.
[24] M. Åsberg,et al. A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.
[25] Keith A. Johnson,et al. MRI-guided SPECT perfusion measures and volumetric MRI in prodromal Alzheimer disease. , 2003, Archives of neurology.
[26] D. Anchisi,et al. Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD , 2006, Neurobiology of Aging.
[27] E. Tangalos,et al. Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .
[28] A. Convit,et al. Reduced hippocampal metabolism in MCI and AD , 2005, Neurology.
[29] B. Dubois,et al. Amnestic syndrome of the medial temporal type identifies prodromal AD , 2007, Neurology.
[30] Susan M Resnick,et al. Longitudinal Cerebral Blood Flow and Amyloid Deposition: An Emerging Pattern? , 2008, Journal of Nuclear Medicine.
[31] D. Perani,et al. MCI conversion to dementia and the APOE genotype , 2004, Neurology.
[32] R. Koeppe,et al. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[33] J. Price,et al. Mild cognitive impairment represents early-stage Alzheimer disease. , 2001, Archives of neurology.
[34] C. Jack,et al. Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.
[35] L. Letenneur,et al. Épidémiologie des troubles de la mémoire. , 1997 .
[36] Alberto Pupi,et al. Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer’s disease using FDG-PET , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[37] Karl J. Friston,et al. A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.
[38] A. Drzezga,et al. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[39] I. Johnsrude,et al. The problem of functional localization in the human brain , 2002, Nature Reviews Neuroscience.
[40] Ove Almkvist,et al. Voxel- and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment , 2003, NeuroImage.
[41] Jean-Claude Baron,et al. Detecting hippocampal hypometabolism in Mild Cognitive Impairment using automatic voxel-based approaches , 2007, NeuroImage.
[42] R. Petersen. Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.
[43] Charles D. Smith,et al. Neuropathologic substrate of mild cognitive impairment. , 2006, Archives of neurology.
[44] B Isaacs,et al. The Set Test as an Aid to the Detection of Dementia in Old People , 1973, British Journal of Psychiatry.
[45] Nathalie Japkowicz,et al. The class imbalance problem: A systematic study , 2002, Intell. Data Anal..
[46] M. Albert,et al. Amnestic MCI or prodromal Alzheimer's disease? , 2004, The Lancet Neurology.
[47] Masatoshi Itoh,et al. Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease. , 2002, The American journal of psychiatry.
[48] K. Schmidtke,et al. High rate of conversion to Alzheimer's disease in a cohort of amnestic MCI patients , 2008, International Psychogeriatrics.
[49] Janet B W Williams,et al. Diagnostic and Statistical Manual of Mental Disorders , 2013 .